These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements. Peltenburg LT; Schrier PI Immunogenetics; 1994; 40(1):54-61. PubMed ID: 8206526 [TBL] [Abstract][Full Text] [Related]
6. Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells. Polack A; Feederle R; Klobeck G; Hörtnagel K EMBO J; 1993 Oct; 12(10):3913-20. PubMed ID: 8404859 [TBL] [Abstract][Full Text] [Related]
7. Enhancers and MYC interplay in hematopoiesis. Benetatos L; Benetatou A; Vartholomatos G J Mol Med (Berl); 2020 Apr; 98(4):471-481. PubMed ID: 32144465 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional Dysregulation of MYC Reveals Common Enhancer-Docking Mechanism. Schuijers J; Manteiga JC; Weintraub AS; Day DS; Zamudio AV; Hnisz D; Lee TI; Young RA Cell Rep; 2018 Apr; 23(2):349-360. PubMed ID: 29641996 [TBL] [Abstract][Full Text] [Related]
9. Cooperative action of multiple cis-acting elements is required for N-myc expression in branchial arches: specific contribution of GATA3. Potvin E; Beuret L; Cadrin-Girard JF; Carter M; Roy S; Tremblay M; Charron J Mol Cell Biol; 2010 Nov; 30(22):5348-63. PubMed ID: 20855530 [TBL] [Abstract][Full Text] [Related]
10. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines. Roland J; Morello D Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795 [TBL] [Abstract][Full Text] [Related]
11. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells. Wang J; Boxer LM J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498 [TBL] [Abstract][Full Text] [Related]
12. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Shi J; Whyte WA; Zepeda-Mendoza CJ; Milazzo JP; Shen C; Roe JS; Minder JL; Mercan F; Wang E; Eckersley-Maslin MA; Campbell AE; Kawaoka S; Shareef S; Zhu Z; Kendall J; Muhar M; Haslinger C; Yu M; Roeder RG; Wigler MH; Blobel GA; Zuber J; Spector DL; Young RA; Vakoc CR Genes Dev; 2013 Dec; 27(24):2648-62. PubMed ID: 24285714 [TBL] [Abstract][Full Text] [Related]
13. Hold the MYCrophone: MYC Invades Enhancers to Control Cancer-Type Gene Programs. MacPherson-Hawthorne K; Sears RC Cancer Res; 2024 Jul; 84(14):2227-2228. PubMed ID: 38695859 [TBL] [Abstract][Full Text] [Related]
14. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Desbarats L; Gaubatz S; Eilers M Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional amplification in tumor cells with elevated c-Myc. Lin CY; Lovén J; Rahl PB; Paranal RM; Burge CB; Bradner JE; Lee TI; Young RA Cell; 2012 Sep; 151(1):56-67. PubMed ID: 23021215 [TBL] [Abstract][Full Text] [Related]
16. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor. Wang C; Mayer JA; Mazumdar A; Fertuck K; Kim H; Brown M; Brown PH Mol Endocrinol; 2011 Sep; 25(9):1527-38. PubMed ID: 21835891 [TBL] [Abstract][Full Text] [Related]
17. MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state. Poli V; Fagnocchi L; Fasciani A; Cherubini A; Mazzoleni S; Ferrillo S; Miluzio A; Gaudioso G; Vaira V; Turdo A; Gaggianesi M; Chinnici A; Lipari E; Bicciato S; Bosari S; Todaro M; Zippo A Nat Commun; 2018 Mar; 9(1):1024. PubMed ID: 29523784 [TBL] [Abstract][Full Text] [Related]
18. Mouse Models of Ferrad M; Ghazzaui N; Issaoui H; Cook-Moreau J; Denizot Y Front Immunol; 2020; 11():1564. PubMed ID: 32793219 [TBL] [Abstract][Full Text] [Related]
19. Zimmerman MW; Liu Y; He S; Durbin AD; Abraham BJ; Easton J; Shao Y; Xu B; Zhu S; Zhang X; Li Z; Weichert-Leahey N; Young RA; Zhang J; Look AT Cancer Discov; 2018 Mar; 8(3):320-335. PubMed ID: 29284669 [TBL] [Abstract][Full Text] [Related]
20. Targeting of noncoding RNAs encoded by a novel MYC enhancers inhibits the proliferation of human hepatic carcinoma cells in vitro. Choi HI; An GY; Yoo E; Baek M; Chai JC; Binas B; Lee YS; Jung KH; Chai YG Sci Rep; 2022 Jan; 12(1):855. PubMed ID: 35039581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]